Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers.

Frontiers in endocrinology(2023)

引用 0|浏览4
暂无评分
摘要
Silencing miR-21, although not showing synergistic activity with TKIs (tyrosine kinase inhibitors), represents a potential alternative worth exploring as a therapeutic target for MTC.
更多
查看译文
关键词
thyroid, medullary thyroid cancer, miR-21, PDCD4, miRNA silencing
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要